ExploreWatchlistsPricing
  1. US-listed companies
  2. Cyclo Therapeutics, Inc.
  3. Financials
  4. Revenue growth (%)

Cyclo Therapeutics, Inc. (CYTH)

Market cap
$20.73M
P/E ratio
SummaryFinancials
Period EndRevenue growth (%) YoY (%)
Dec 31, 2023-21.8+64.35%
Dec 31, 2022-13.2-117.53%
Dec 31, 202175.5-832.69%
Dec 31, 2020-10.3+2354.76%
Dec 31, 2019-0.4-97.70%
Dec 31, 2018-18.3+3.63%
Dec 31, 2017-17.6-130.35%
Dec 31, 201658.1-247.69%
Dec 31, 2015-39.4+429.74%
Dec 31, 2014-7.4-111.97%
Dec 31, 201362.1+4785.83%
Dec 31, 20121.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat